Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIcfg Limited Regulatory News (ICFG)

  • This share is currently suspended. It was suspended at a price of 14.50

Share Price Information for Icfg Limited (ICFG)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £29.57m
ICFG Live PriceLast checked at - London Stock Exchange

Intraday Icfg Limited Share Chart

Interim Results - Correction

23 Apr 2026 14:13

RNS Number : 7117B
ICFG Limited
23 April 2026
Β 

23 April 2026

ICFG Limited

("ICFG" or the "Company")

Interim Results - Correction

ICFG Limited (LON: ICFG), the international financial services group, announces the following corrections in respect of its unaudited interim results for the six months ended 30 June 2025 which were announced on 29 September 2025 ("H1-2025 Interim Results").

Accounting treatment of the reverse acquisition

Following further review of the accounting treatment of the reverse takeover of ICFG Pte Ltd completed on 12 February 2025 ("Reverse Takeover"), the reported Share-based Payment Expense on Reverse Takeover of USD 154.9 million recognised in the unaudited condensed statement of comprehensive income for H1-2025 Interim Results has been determined to be overstated. Upon correct application of IFRS 2 Share-based Payment ("IFRS 2"), the Share-based Payment Expense on Reverse Takeover is amended to be approximately USD 16.0 million. This adjustment is non-cash in nature and relates solely to the accounting valuation of the Share-based Payment Expense arising from the Reverse Takeover.

The Company confirms that the board of ICFG has determined that the accounting for the Reverse Takeover should be in accordance with IFRS 2, consistent with the disclosure in Note 25 of the H1-2025 Interim Results, on the basis that the legal parent does not constitute a business. This treatment differs from the accounting approach described in the Company's prospectus published on 22 January 2025, which contemplated application of IFRS 3 Business Combinations. The correct application of IFRS 2 also impacts presentation adjustments in other parts of the accounts, including to the equity structure (reflecting Reverse Takeover accounting) and the classification within the statement of cash flows. These adjustments do not affect the Group's underlying financial performance or cash position.Β The Company is aligning its final accounting treatment with the required presentation under IFRS 2 and will provide further details in its audited financial statements for the year ended 31 December 2025.

Borrowed funds

The Company also wishes to correct the statement included in Note 15 Borrowed Funds of the H1-2025 Interim Results that the Group was fully compliant with contractual covenants imposed by its lenders as of 30 June 2025. This statement was incorrect. Certain financial covenant breaches had occurred prior to 30 June 2025 with certain lenders. The Company confirms that a waiver in respect of the relevant breaches, covering the applicable reporting period up to 30 June 2025, had been approved in August 2025 and that no event of default was declared, nor were any amounts accelerated or immediately payable as a result of such breaches. The Company is continuing its engagement with relevant lenders in respect of covenant compliance and will provide further updates as appropriate.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019.

Β 

For further information, please contact:

Β 

ICFG Limited

Enkhmaral Batkhuyag, CEO

ir@ic-fg.com

Β 

Strand Hanson Limited (Financial Adviser)

Rory Murphy / Abigail Wennington / Harry Marshall

+44 (0) 207 409 3494

Β 

SP Angel Corporate Finance LLP (Joint Broker)

Stuart Gledhill

+44 (0) 203 470 0470

Β 

AlbR Capital Limited (Joint Broker) formerly Novum Securities

Jon Bellis / Colin Rowbury

+44 (0) 207 399 9400

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRIJMJTMTBTBMF
Date   Source Headline
27th May 202611:37 amRNSFY25 Audited Consolidated Results SIBJ Capital LLC
1st May 20267:51 amRNSTemporary Suspension of Listing
30th Apr 202610:12 amRNSFY25 Principal Subsidiary Results & Covenants
23rd Apr 20262:13 pmRNSInterim Results - Correction
20th Apr 20266:03 pmRNSDelay in publication of audited results
20th Mar 20261:31 pmRNSAppointment of Joint Broker
2nd Mar 20262:32 pmRNSBoard and Management Changes
17th Feb 20267:00 amRNSSubsidiary Dividend Declaration
13th Feb 20267:00 amRNSLoan Facility Second Disbursement
3rd Feb 20267:00 amRNSSubsidiary Governance and Management Changes
2nd Feb 20267:41 amRNSAppointment of Chief Financial Officer
23rd Dec 20251:56 pmRNSResult of AGM
23rd Dec 20251:56 pmRNSResult of AGM
3rd Dec 20257:00 amRNSNotice of AGM
19th Nov 20258:34 amRNSAppointment of Independent Non-Executive Director
4th Nov 20258:53 amRNSLoan Facility Announcement
30th Oct 20257:00 amRNSChange of Auditor
23rd Oct 20259:39 amRNS-RInvestor Presentation at Mongolia Investment Forum
29th Sep 20257:00 amRNSInterim Results
16th Sep 20255:01 pmRNSLoan Note Instrument
8th Sep 20257:00 amRNSSIBJ Group Annual Report 2024
27th Aug 20257:00 amRNSInvescore NBFI Secures US$20m Funding
20th Aug 20257:00 amRNSBoard and Management Changes
12th Aug 20257:00 amRNS-RConnect Life - Life Insurance Licence in Mongolia
22nd Jul 20257:00 amRNSInvescore NBFI JSC Semi-Annual Operational Report
29th Apr 20257:00 amRNSFinal Results for the year ended 31 December 2024
28th Apr 20257:00 amRNSInvescore NBFI JSC 2024 Operational Report
15th Apr 20257:00 amRNSInvescore NBFI JSC Audited Financial Statements
1st Apr 20253:31 pmRNSSIBJ Capital enters Investment Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.